Blog Hero

Multi-center study of ILUVIEN implant treatments demonstrates improvements for patients with vision loss due to diabetic macular edema

Book Appointment
alt_placeholder

Retina Health Center has presented results of a national, multi-center study of ILUVIEN involving retinal patients from four centers including Cincinnati Eye, Georgia Retina, Retina Health Center and Southern Eye. The findings of the study were presented at the 18th EURETINA Congress in Vienna, Austria by Dr. Alexander Eaton, founder and director of Retina Health Center in Southwest Florida. Euretina is the largest retinal conference in the world.

The objectives of the retrospective chart study were to determine ocular outcomes in patients receiving ILUVIEN implants for the treatment of diabetic macular edema (DME), a complication of diabetes caused by accumulation of fluid in the macula or central portion of the eye and a leading cause of vision loss in people with diabetes. 

Approved by the U.S. Food and Drug Administration (FDA) for DME treatment, ILUVIEN releases and maintains a concentration of steroids inside the eye for up to three years. A tiny tube is inserted in the back of the eye where DME typically forms, and the implant slowly releases a corticosteroid over the course of 36 months.

Researchers from Retina Health Center analyzed data from 160 eyes of 130 patients who had at least one year of follow-up care following injection of the ILUVIEN implant. According to the data, most patients in the study had chronic DME.

“The results of this study have significant implications on reducing the treatment burden on patients with diabetic macular edema,” said Eaton. “For patients that receive frequent injections and/or laser treatment, the findings indicate that the ILUVIEN may be a more appealing option as it can reduce treatment frequency from once every 2-3 months to once every 22 months in the best case (patients with better than 20/40 vision) and to once every 6-7 months in the worst case (patients with less than 20/200 vision). Since no one likes injections, which involve having a needle inserted into the white of the eye, as you might imagine, this transformational medication has been very well received by our patients.”

Retina Health Center was the first site selected to offer this promising medication following its FDA approval for treatment for DME in 2014. Retina Health Center and the Macular Degeneration Research Center were established in 2002 by Dr. Alexander M. Eaton, a long-time Southwest Florida resident, who has been practicing ophthalmology in Lee and Collier counties for more than 20 years. Dr. Eaton has been the principal investigator for numerous studies to prevent and treat macular degeneration, and has invented numerous medical devices for use by patients and physicians that are used worldwide. For more information on the latest studies or to make an appointment, call 239-337-3337 in Fort Myers or 239-793-5200 in Naples.

Locations

We have two convenient locations in Southwest Florida. View the nearest location to you or get directions below.

    See Our Google Reviews

    Google
    5.0/5
    Oct 11, 2023
    Google Retina Health Center: Alexander Eaton M.D.
    I have been treated by numerous macular specialists in Michigan and Florida over the years. I have found Dr Eaton and his associates to be the top of this group. He is smart, courteous, and carrying. His staff are polite and competent. With a recent severe medical eye emergency he stayed late, and followed up to assure my eye was successfully treated.
    Google
    5.0/5
    Jun 23, 2023
    Google Retina Health Center: Fort Myers
    My Dr. here is amazing..The best I could ask for…
    Google
    5.0/5
    Jun 21, 2023
    Google Retina Health Center: Fort Myers
    Dr Gravelsen is best giving shots in the eye. I have shots for over 15 years ever month and she is the best.

    News

    Ensuring Eye Safety During the Solar Eclipse

    News & Updates

    As the date of the upcoming solar eclipse draws near, the Retina Health Center team would like to underscore the paramount importance of safeguarding your vision during this rare celestial event. While witnessing a solar eclipse can be an awe-inspiring experience, it is imperative to prioritize ocular safety to prevent potential harm to your eyesight. […]

    Read More…

    April 5, 2024
    useye

    Dr. Alexander Eaton introduces XactDrop, new device for improving eye drop delivery

    Uncategorized

    Retina Health Center Founder and Director Dr. Alexander Eaton has created and introduced XactDrop, an eye drop applicator guide designed to help patients more accurately deliver eye drops. XactDrop is suitable for people of all ages and can be used by anyone using eye drops, including cataract and glaucoma patients, contact lens wearers, those using […]

    Read More…

    October 23, 2018
    useye

    Multi-center study of ILUVIEN implant treatments demonstrates improvements for patients with vision loss due to diabetic macular edema

    Uncategorized

    Retina Health Center has presented results of a national, multi-center study of ILUVIEN involving retinal patients from four centers including Cincinnati Eye, Georgia Retina, Retina Health Center and Southern Eye. The findings of the study were presented at the 18th EURETINA Congress in Vienna, Austria by Dr. Alexander Eaton, founder and director of Retina Health Center […]

    Read More…

    October 9, 2018
    useye

    As the date of the upcoming solar eclipse draws near, the Retina Health Center team would like to underscore the paramount importance of safeguarding your vision during this rare celestial event. While witnessing a solar eclipse can be an awe-inspiring experience, it is imperative to prioritize ocular safety to prevent potential harm to your eyesight. […]

    Read More…

    alt_dr_alexander_eaton_introduces_xactdrop_new_device_for_improving_eye_drop_delivery

    Retina Health Center Founder and Director Dr. Alexander Eaton has created and introduced XactDrop, an eye drop applicator guide designed to help patients more accurately deliver eye drops. XactDrop is suitable for people of all ages and can be used by anyone using eye drops, including cataract and glaucoma patients, contact lens wearers, those using […]

    Read More…

    alt_placeholder

    Retina Health Center has presented results of a national, multi-center study of ILUVIEN involving retinal patients from four centers including Cincinnati Eye, Georgia Retina, Retina Health Center and Southern Eye. The findings of the study were presented at the 18th EURETINA Congress in Vienna, Austria by Dr. Alexander Eaton, founder and director of Retina Health Center […]

    Read More…

    For more information on the latest studies or to make an appointment,
    call 239-544-3279 in Fort Myers or 239-766-7140 in Naples.

    instagram facebook facebook2 pinterest twitter google-plus google linkedin2 yelp youtube phone location calendar share2 link star-full star star-half chevron-right chevron-left chevron-down chevron-up envelope fax